All In Biotech

Drug Trial Radar · NCT01502306

A Randomized Trial of Medi-Cal Beneficiaries Calling the California Smokers' Helpline

Last checked: Nov 19, 2026Latest source record: Feb 13, 2020 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedResults posted on the registryPivotal-lookingPhase 3. Randomized with 3,816 participants. This is a heuristic, not a regulatory label.

Status

Completed

Enrollment

3,816

Actual

Start

Jun 2012

Primary completion

Feb 2014

Study completion Feb 2014

Sponsor

Lead sponsor
University of California, San DiegoAcademic, hospital or other
Sponsor type
Academic, hospital or other
Collaborators
Centers for Medicare and Medicaid Services; University of California, San Francisco; California Department of Public Health; California Department of Health Services
First posted
Dec 30, 2011

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 3
Allocation
Randomized
Model
Parallel
Masking
None
Primary purpose
Treatment
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

California Smokers' Helpline will conduct a randomized trial to evaluate 3 strategies of services and/or incentives on smoking cessation rates. This project has the following specific aims: 1. To increase tobacco cessation among Medi-Cal beneficiaries who currently smoke, and to improve the management of diabetes and other chronic disease by means of tobacco cessation. 2. Demonstrate that tobacco cessation benefits that are well promoted and barrier free and include modest incentives, are effective in reducing smoking prevalence, lowering Medi-Cal health care costs, and improving health outcomes for diabetes management in particular.

Conditions

  • Smoking Cessation

Interventions

  • Telephone counselingBehavioral

    Telephone counseling is conducted in the appropriate language (Spanish and English) by counselors at the California Smokers' Helpline. Counselors use a structured protocol and there is a record for each call. Quantitative information that will be available for analysis include: timing, length, and frequency of counseling calls.

  • Nicotine patchesDrug

    Clients will be screened for contraindications to nicotine patch use, and a doctor's approval will be necessary before patches are sent if a contraindication exists.

  • IncentiveBehavioral

    They will be given their choice of gift cards from one of 4 major business chains: Wal-Mart, Target, Vons/Safeway, or Ralph's/Kroger card.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. 30-day AbstinenceTime frame: 7 months post enrollment

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • University of California, San Diego; California Smokers' Helpline

    San Diego, California

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.